Wendy Stock to Hydroxamic Acids
This is a "connection" page, showing publications Wendy Stock has written about Hydroxamic Acids.
Connection Strength
0.487
-
A phase I and pharmacodynamic study of the histone deacetylase inhibitor belinostat plus azacitidine in advanced myeloid neoplasia. Invest New Drugs. 2015 Apr; 33(2):371-9.
Score: 0.487